Douglas Hamilton
President and CEO, Vasomune Therapeutics
Charter Member
San Fransisco, CA
  • Former President & CEO at Metastat, a precision medicine company dedicated to improving survival of patients with aggressive cancer
  • Previously CFO for SEA Medical Systems and the Founder and Partner at New Biology Ventures (incubator accelerator and consulting firm)
  • Previously the CFO and COO for Javelin Pharmaceuticals, where he helped build a late-stage product pipeline, took the company public, and raised over $82M in financing

Expertise: Cultivating life-science tech innovation through a broad and multidisciplinary domain expertise

Canadian Connection: from Toronto, B.Sc. from University of Toronto, M.B.A. from Western University

Back to Members